The subthalamic nucleus (STN) is a common target for deep brain stimulation (DBS) treatment in Parkinson’s disease (PD) but much less frequently targeted for other disorders. Here we report the results of simultaneous local field potential (LFP) recordings and magnetoencephalography (MEG) in a single patient who was implanted bilaterally in the STN for the treatment of dystonia induced by chorea-acanthocytosis. Consistent with the previous results in PD, the dystonia patient showed significant subthalamo-cortical coherence in the high beta band (28–35 Hz) on both sides localized to the mesial sensorimotor areas. In addition, on the right side, significant coherence was found in the theta-alpha band (4–12 Hz) that localized to the medial pre...
In Parkinson's disease (PD), subthalamic nucleus beta band oscillations are decreased by therapeutic...
Activation of the basal ganglia has been shown during the preparation and execution of movement. How...
AbstractObjectiveDopaminergic treatment of patients with Parkinson’s disease can be associated with ...
The subthalamic nucleus (STN) is a common target for deep brain stimulation (DBS) treatment in Parki...
OBJECTIVES: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been successfully used...
*These authors contributed equally to this work. Primary dystonia has been associated with an underl...
Background: Local field potentials were recorded from the subthalamic nucleus (STN) in a patient wit...
AbstractObjectiveIt has been suggested that abnormal synchronization and oscillation of neuronal act...
The subthalamic nucleus (STN) is a primary target for deep brain stimulation in Parkinson's disease ...
Objectives Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been successfully used ...
AbstractFunctional neurosurgical techniques provide a unique opportunity to explore patterns of inte...
BACKGROUND: Subthalamic nucleus (STN) stimulation is an effective treatment for Parkinson's disease ...
ImportanceIsolated dystonia and Parkinson disease (PD) are disorders of the basal gangliothalamocort...
Parkinson’s disease (PD) and dystonia are movement disorders related to dysfunctions of basal gangli...
In this paper we investigated the dopaminergic modulation of neuronal interactions occurring in the ...
In Parkinson's disease (PD), subthalamic nucleus beta band oscillations are decreased by therapeutic...
Activation of the basal ganglia has been shown during the preparation and execution of movement. How...
AbstractObjectiveDopaminergic treatment of patients with Parkinson’s disease can be associated with ...
The subthalamic nucleus (STN) is a common target for deep brain stimulation (DBS) treatment in Parki...
OBJECTIVES: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been successfully used...
*These authors contributed equally to this work. Primary dystonia has been associated with an underl...
Background: Local field potentials were recorded from the subthalamic nucleus (STN) in a patient wit...
AbstractObjectiveIt has been suggested that abnormal synchronization and oscillation of neuronal act...
The subthalamic nucleus (STN) is a primary target for deep brain stimulation in Parkinson's disease ...
Objectives Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been successfully used ...
AbstractFunctional neurosurgical techniques provide a unique opportunity to explore patterns of inte...
BACKGROUND: Subthalamic nucleus (STN) stimulation is an effective treatment for Parkinson's disease ...
ImportanceIsolated dystonia and Parkinson disease (PD) are disorders of the basal gangliothalamocort...
Parkinson’s disease (PD) and dystonia are movement disorders related to dysfunctions of basal gangli...
In this paper we investigated the dopaminergic modulation of neuronal interactions occurring in the ...
In Parkinson's disease (PD), subthalamic nucleus beta band oscillations are decreased by therapeutic...
Activation of the basal ganglia has been shown during the preparation and execution of movement. How...
AbstractObjectiveDopaminergic treatment of patients with Parkinson’s disease can be associated with ...